Access to UK Biobank data by researchers based in China has sparked headlines in the UK about potential security concerns, but the risks have been overblown, according to the research organisation.

For pharmaceutical, biotech, and medtech companies eyeing global expansion, the NHS presents a paradox. It is one of the UK's most treasured institutions, providing universal healthcare to millions ...